Jung IH, Lee SY, Lee SJ, Lee JY, Park NJ, Ahn DS, Jung JH, Shin DH, Lim DS. Device closure of a large atrial septal defect in a patient with severe pulmonary arterial hypertension after 1 year use of an oral endothelin receptor antagonist.
J Cardiovasc Ultrasound 2013;
21:140-4. [PMID:
24198921 PMCID:
PMC3816165 DOI:
10.4250/jcu.2013.21.3.140]
[Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2013] [Revised: 05/29/2013] [Accepted: 08/12/2013] [Indexed: 11/22/2022] Open
Abstract
The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan.
Collapse